ABSTRACT
Aims The clinical manifestation of type 2 diabetes (T2D) varies across populations. We compared the phenotypic characteristics of Black Africans and White Europeans with recently diagnosed T2D to understand the ethnic differences in the manifestation of T2D.
Methods We searched Medline, EMBASE, CINAHL, Google Scholar, African Index Medicus, and Global Health for studies reporting information on phenotypic characteristics in Black Africans and White Europeans with recently diagnosed T2D.
Results A total of 26 studies were included in this systematic review. Of these, 12 studies and 14 studies were conducted on 2,586 Black Africans in eight countries and 279,621 White Europeans in nine countries, respectively. Compared with White Europeans, Black Africans had a lower pooled mean age (49.4±4.4 years vs. 61.3±2.7 years), body mass index (26.1±2.6 kg/m2 vs. 31.4±1.1 kg/m2), and a higher pooled median glycated haemoglobin (9.0 [8.0-10.3]% vs. 7.1 [6.7-7.7]%). Ugandan and Tanzanian participants had lower markers of beta-cell function and insulin resistance when compared with four White European populations.
Conclusion These findings provide evidence of the ethnic differences in the manifestation of T2D, underscoring the importance of understanding the underlying genetic and environmental factors influencing these phenotypic differences and formulating ethnic-specific approaches for managing and preventing T2D.
HIGHLIGHTS
Emerging evidence suggests differences in the presentation of type 2 diabetes in Black Africans and White Europeans.
In this systematic review, we reported that compared with White Europeans, Black Africans presented with a lower mean age and body mass index, less co-existing hypertension, and more hyperglycaemia at the time of diagnosis of type 2 diabetes.
Compared with some White European populations, Ugandan and Tanzanian participants presented with features of pancreatic beta-cell dysfunction and less insulin resistance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used already published studies that are available online.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
